- Exchange: SIX Swiss Ex
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Basilea Pharmaceutica+ Add to Watchlist
BSLN:SW121.50 CHF 0.70 0.57%
As of 12:53:40 ET on 02/27/2015.
Company Profile for Basilea Pharmaceutica (BSLN)
Basilea Pharmaceutica AG is a biotechnology company conducting research into the development of drugs for the treatment of infectious diseases and dermatological problems. The Company develops anti-bacterial and anti-fungal compounds which destroy infectious organisms.
Key Executives for Basilea Pharmaceutica (BSLN)
|Domenico ScalaVice Chairman||Ronald Scott "Ron"Chief Executive Officer|
|Donato SpotaChief Financial Officer||David VeitchChief Commercial Officer|
|Ingrid Heinze-KraussChief Technology Officer||Achim KaufholdChief Medical Officer|
|Laurenz KellenbergerChief Scientific Officer||Barbara ZinkHead:Corporate Development|
|Heidi McDaidHead:Global Human Resources|